Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 536
Name: Organic compounds -- part of the class 532-570 series >
Description:


Class Number Class Name No. of Patents
 

Organic compounds (class 532, subclass 1)

 
536/1.11

Carbohydrates or derivatives

591
536/3

Algin or derivative

128
536/56

Cellulose or derivative

473
536/58

Esters

141
536/63

Carboxylic acid esters

141
536/69

Acetates

139
536/83

Halogen containing compound utilized in process

12
536/76

Subsequent treatment process

92
536/77

Comminuting or centrifuging

11
536/79

Corrosiveness reduced

6
536/82

Halogen containing compound utilized in process

21
536/78

Recovery from photographic film

7
536/81

Stabilizing

11
536/80

Viscosity or degree of polymerization changed (e.g., degrading, cross linking, etc.)

35
536/70

With pretreatment process

32
536/71

Acetic acid utilized in pretreatment

29
536/72

Halogen containing compound utilized in process

8
536/73

Sulfur containing compound utilized in pretreatment

10
536/75

Halogen containing compound utilized in process

6
536/74

Sulfur containing compound utilized in pretreatment

8
536/66

Ether-esters

45
536/67

Formates

17
536/64

Mixed carboxylate esters

61
536/65

Propionate, butyrate or isobutyrate containing

56
536/68

Propionates, butyrates or isobutyrates

46
536/62

Phosphorus containing acid

30
536/59

Sulfur containing acid

68
536/60

Xanthate or viscose

36
536/61

Subsequent treatment process

33
536/84

Ethers

223
536/99

Alkyl or cycloalkyl

68
536/100

Ethyl

41
536/97

Carboxyalkyl or salts thereof

47
536/98

Carboxymethyl or salts thereof

113
536/95

Hydroxyalkyl containing

97
536/96

Hydroxyethyl

88
536/90

Mixed ethers

105
536/91

Hydroxyalkyl containing

136
536/85

Subsequent treatment process

94
536/89

Acid employed in subsequent treatment

29
536/86

Comminuting

24
536/87

Liquid interaction properties changed (e.g., solubility, absorbability, etc.)

63
536/88

Viscosity, degree of polymerization or heat stability changed (e.g., degrading, cross-linking, etc.)

86
536/92

Sulfur containing

41
536/93

Unsaturated

25
536/94

Aromatic nucleus containing

14
536/101

Metal containing

59
536/57

Regenerated cellulose

120
536/112

Dextran or derivative

226
536/113

Iron containing

30
536/115

Esters

326
536/119

Carboxylic

432
536/116

Ether-esters

109
536/117

Phosphorus containing

178
536/118

Sulfur containing

205
536/120

Ethers

446
536/114

Gums or derivatives

382
536/121

Metal containing

180
536/18.7

Nitrogen containing

685
536/29.2

C-glycosides wherein the sugar ring is bonded directly to carbon of an n-hetero ring (e.g., 9-deazaadenosines, etc.)

47
536/30

Cellulose derivatives

141
536/32

Esters

71
536/35

Nitrates

23
536/36

Mixed esters

17
536/38

Subsequent treatment process

28
536/39

Comminuting

2
536/40

Recovery from photographic film

3
536/42

Stabilizing

4
536/41

Viscosity or degree of polymerization changed (e.g., degrading, cross linking, etc.)

21
536/37

With pretreatment process

9
536/34

Phosphorus containing acid

11
536/33

Sulfur containing acid

20
536/43

Ethers

89
536/44

Mixed ethers

43
536/31

Nitrogen containing hetero ring (e.g., morpholine, etc.)

43
536/20

Chitin or derivative

341
536/51

Dextran derivatives

105
536/55.2

Glucosamine containing

310
536/52

Gum derivatives

60
536/21

Heparin or derivative

341
536/22.1

N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.)

1846
536/25.2

2`-5` linked rna

58
536/25.1

3`-5` linked rna

120
536/23.1

Dna or rna fragments or modified forms thereof (e.g., genes, etc.)

13888
536/23.4

Encodes a fusion protein

2288
536/23.7

Encodes a microbial polypeptide

2647
536/23.71

Bacillus thuringiensis insect toxin

292
536/23.74

Fungal protein

279
536/23.72

Viral protein

1500
536/23.6

Encodes a plant polypeptide

2009
536/23.5

Encodes an animal polypeptide

6942
536/23.51

Hormone

596
536/23.53

Immunoglobulin

485
536/23.52

Interferon

176
536/23.2

Encodes an enzyme

6712
536/24.2

Non-coding sequences having no known regulatory function which are adaptors or linkers for vector or gene contruction

425
536/24.1

Non-coding sequences which control transcription or translation processes (e.g., promoters, operators, enhancers, ribosome binding sites, etc.)

3772
536/24.5

Nucleic acid expression inhibitors

2095
536/24.3

Probes for detection of specific nucleotide sequences or primers for the synthesis of dna or rna

4935
536/24.33

Primers

3178
536/24.31

Probes for detection of animal nucleotide sequences

2774
536/24.32

Probes for detection of microbial nucleotide sequences

1799
536/25.5

Homopolymers having repeating sequences of four or more identical nucleotide units

72
536/28.6

N-glycosides wherein the n is part of a five-membered hetero ring (e.g., selenazole nucleosides, pyrrole nucleosides, etc.)

63
536/28.7

Plural nitrogens in the n-hetero ring (e.g., triazoles, etc.)

50
536/28.8

The n-hetero ring is a 1,3-diazole ring, including hydrogenated (e.g., imidazoles, etc.)

51
536/28.9

Benzimidazoles

29
536/28.1

N-glycosides wherein the n is part of a six-membered hetero ring (e.g., diazines, etc.)

194
536/28.2

Multideoxy or didehydro

157
536/28.4

The n-hetero ring is a 1,3-diazine ring, including hydrogenated (e.g., pyrimidines, etc.)

116
536/28.53

Chalcogen bonded directly to the 2- and 4-positions of the diazine ring (e.g., uridine, etc.)

259
536/28.54

Alkyl, or substituted alkyl, bonded directly to the 5-position of the diazine ring (e.g., thymidine, 5-methyl uridine, etc.)

230
536/28.55

Halogen bonded directly to the 5-position of the diazine ring (e.g., 5-fluorouridine, etc.)

141
536/28.5

Nitrogen, other than nitro or nitroso, bonded directly to the 4-position, and chalcogen bonded directly to the 2-position of the diazine ring (e.g., cytidines, etc.)

282
536/28.52

Halogen or alkyl group of 1-5 carbon atoms bonded directly to the 5-position of the diazine ring

140
536/28.51

Having chalcogen, carbonyl, or thiocarbonyl bonded directly to the 4-position substituent nitrogen

103
536/28.3

The n-hetero ring is a triazine ring, including hydrogenated (e.g., 6-azauridine, etc.)

42
536/27.1

N-glycosides wherein the n is part of an n-hetero ring which hetero ring is part of a polycyclo ring system containing an n-hetero ring and an additional hetero ring (e.g., rebeccamycin, etc.)

178
536/27.13

Bicyclic ring system consisting of the n-hetero ring fused to another hetero ring (e.g., 2-azaadenines, 6-azaadenines, etc.)

127
536/27.14

Multideoxy or didehydro

145
536/27.2

The bicyclic ring system consists of a 1,3-diazine ring, which may be hydrogenated, fused to a five-membered n-hetero ring (e.g., purine isoesters like tubercidin, toyocamycin, sangivamycin, sparsomycin a, etc.)

100
536/27.21

The five-membered n-hetero ring is 1,3-diazole, which may be hydrogenated (e.g., 6-chloropurine nucleoside, nebularin, etc.)

114
536/27.4

Arabinose is sugar moiety

70
536/27.23

Carbonyl, thiocarbonyl, additional hetero ring or nitrogen, other than as nitro or nitroso, attached indirectly to the sugar ring by acyclic nonionic bonding

70
536/27.3

Adenosyl

111
536/27.31

S-adenosyl-l-methionine, s-adenosyl-l-homocysteine, salts, or esters thereof

33
536/27.22

Carbonyl, thiocarbonyl, or nitrogen, other than as nitro or nitroso, bonded directly to the sugar ring

54
536/27.8

Chalcogen bonded directly to the 6- or 2-position of a purine ring system (e.g., inosine, etc.)

139
536/27.81

Nitrogen, other than nitro or nitroso, bonded directly to the 2-position of the purine ring system (e.g., guanosine, etc.)

191
536/27.5

Ketose is sugar moiety (e.g., decoyinine, psicofuranosylpurines, etc.)

7
536/27.6

Nitrogen, other than nitro or nitroso, bonded directly to the 6-position of a purine ring system (e.g., adenosine, etc.)

262
536/27.61

Additional nitrogen bonded directly to the 2-position of the purine ring system

103
536/27.7

Chalcogen, halogen, or benzene bonded directly to carbon of the purine ring system (e.g., isoguanosine, 2-fluoroadenosine, etc.)

92
536/27.62

Nitrogen, chalcogen, or additional carbon bonded directly to the 6-position nitrogen (e.g., 6-position nitrogen is substituted, etc.)

159
536/27.63

Halogen, chalcogen, or cyano bonded directly to the 2-position of the purine ring system

130
536/27.11

Preparing by cleaving nucleic acids or by attaching an n-heterocyclic base to a sugar ring

109
536/27.12

Separation or purification (e.g., resolving isomeric mixtures, etc.)

36
536/29.1

Nitrogen of n-glycoside is acyclic nitrogen

95
536/29.11

N-hetero ring bonded directly or indirectly to the acyclic nitrogen

30
536/29.13

Sulfur containing (e.g., sulfides, sulfones, sulfates, sulfonamides, etc.)

9
536/29.12

The acyclic nitrogen is part of a urea or thiourea group

47
536/25.6

Nucleic acids which include two or three nucleotide units

146
536/26.1

Phosphorus containing n-glycoside wherein the n is part of an n-hetero ring

175
536/26.44

Cobalamin analogs (i.e., compounds wherein the benzimidazole ring system has been replaced by another organic ring structure, or compounds wherein cobalt has been removed or replaced by another metal, or is substituted by a group other than -oh or -cn)

26
536/26.4

Cobalamin nucleotides (e.g., vitamin b-12, etc.)

44
536/26.42

Processes of concentraction, separation, recovery, or extraction (e.g., recovery from organ extracts, from fermentation broth, from sewage sludge, etc.)

13
536/26.43

Adsorbent used (e.g., activated alumina, ion exchange resins, etc.)

6
536/26.41

Processes of preparing or labelling

26
536/26.6

Labelled (e.g., tagged with radioactive tracer, fluorescent marker, intercalator, etc.)

406
536/26.5

Plural n-glycosidic moieties bonded to the same phosphorus ester group

48
536/26.2

Plural phosphorus atoms in n-glycoside

45
536/26.3

Plural monophosphate groups (e.g., adenosine-3`, 5`-biscarboxymethyl phosphonate, cytidine nucleoside diphosphate, etc.)

36
536/26.21

Plural phosphorus atoms bonded directly to the same chalcogen in a chain (e.g., pyrophosphates, polyanhydrides of phosphorus acids, etc.)

58
536/26.22

Both terminal phosphorus atoms are esterified by organic groups wherein one of these organic groups is the sugar moiety

35
536/26.23

Exactly two phosphorus atoms in the chain (e.g., coenzyme a, etc.)

128
536/26.25

Fad (flavin adenine dinucleotide) and derivatives thereof

14
536/26.24

Nad (nicotinamide adenine dinucleotide) and derivatives thereof

52
536/26.26

Triphosphates (in same chain)

170
536/26.9

The n-hereto ring is five-membered (e.g., 1- -d-riboburanosyl-1, 2,3- triazole-4-carboxamide-5`-phosphate, etc.)

42
536/26.8

The n-hereto ring is six-membered and monocyclic (e.g., uridine-5`-mono- phosphate, etc.)

264
536/26.7

The n-hetero ring is part of a bicyclic ring system

250
536/26.74

Inosine nucleotide

49
536/26.71

Preparing purine nucleotides

103
536/26.72

Guanosine nucleotide preparation

48
536/26.73

Separation or purification of purine nucleotides

26
536/26.11

The phosphorus is part of a ring

19
536/26.14

The n-hetero ring is a diazine or a diazole ring, including hydrogenated

19
536/26.12

The n-hetero ring is part of a purine ring system

42
536/26.13

Adenine or substituted adenine

72
536/25.4

Separation or purification of polynucleotides or oligonucleotides

658
536/25.41

Extraction processes (e.g., solvent extraction process, etc.)

194
536/25.42

Denaturant utilized

102
536/25.3

Synthesis of polynucleotides or oligonucleotides

1530
536/25.31

Deprotection step

291
536/25.32

Labels or markers utilized (e.g., radiotracer, affinity, fluoroescent, phosphorescent, markers, etc.)

703
536/25.33

Pentavalent phosphorus compound utilized

247
536/25.34

Trivalent phosphorus compound utilized

361
536/53

Oxygen double bonded and nitrogen bonded directly to the same carbon

532
536/55

Plural nitrogens containing

202
536/55.1

Polysaccharides

417
536/55.3

Processes

394
536/45

Starch derivatives

127
536/47

Cross-linked

30
536/46

Dextrin derivatives

135
536/48

Esters

50
536/49

Ether-esters or mixed esters

29
536/50

Ethers

84
536/54

Sulfur containing

173
536/4.1

O- or s- glycosides

1340
536/4.4

Aescin or derivative

12
536/13.1

Antibiotic bm 123 or derivative

12
536/13.4

Antibiotic xk or derivative

22
536/16.8

Antibiotics

364
536/16.9

Purification or recovery

38
536/17.1

Boron, phosphorus, heavy metal or aluminum containing

158
536/13.5

Butirosin or derivative (e.g., ambutyrosin, etc.)

29
536/18.2

Containing -c(=x)x- wherein the x's are the same or diverse chalcogens

175
536/8.8

Coumermycin or derivative

5
536/5

Cyclopentanohydrophenanthrene ring system

218
536/6.1

Oxygen containing five-membered hetero ring

55
536/6.2

Nitrogen, phosphorus or halogen containing

36
536/6.3

Processes of extracting from plant materials

18
536/6

Oxygen containing six-membered hetero ring (e.g., oxathiane, etc.)

58
536/6.4

Daunomycin or derivative

364
536/8

Flavon sugar compounds

118
536/16.1

Fortimicin or derivative

91
536/13.6

Gentamicin or derivative

101
536/18.4

Halogen containing

143
536/13.7

Kanamycin or derivative

84
536/13.8

Carbonyl bonded directly to kanamycin nitrogen

66
536/16.7

Kasugamycin or derivative

3
536/16.2

Lincomycin or derivative

23
536/16.4

Additional sulfur containing

5
536/16.3

Cyano or -coo- containing

9
536/16.5

Phosphorus or halogen containing

17
536/16.6

Neamine or derivative (e.g., neomycin a, etc.)

44
536/13.2

Neomycin b or neomycin c or derivative

28
536/17.2

Nitrogen containing

567
536/17.7

Nitro or nitroso containing

51
536/17.8

Nitrogen in aglycone moiety

24
536/17.3

Nitrogen containing hetero ring

167
536/17.4

Nitrogen in aglycone moiety

275
536/17.9

Nitrogen in aglycone moiety

355
536/17.5

Sulfur containing (e.g., methylthiolincosaminide, etc.)

158
536/17.6

Nitrogen or sulfur in aglycone moiety

110
536/13

Novobiocin or derivative

11
536/7.1

Oxygen containing hetero ring having 12-19 members (e.g., methymycin, carbomycin, spiramycin, etc.)

361
536/7.2

Erythromycin or derivative (e.g., oleandomycin, etc.)

314
536/7.4

Additional nitrogen containing

352
536/7.3

Boron, phosphorus or sulfur containing

87
536/7.5

Purification or recovery

24
536/6.5

Oxygen containing hetero ring having at least twenty members (e.g., amphotericin, nystatin, pimaricin, etc.)

98
536/13.3

Paromomycin or derivative (e.g., neomycin e, etc.)

28
536/18.3

Plural oxyalkylene groups bonded directly to each other

69
536/18.1

Polycyclo ring system (e.g., hellebrin, etc.)

445
536/18.5

Processes

663
536/18.6

Reacting a carbohydrate with an organic -o- containing compound (e.g., reacting glucose with methanol, etc.)

400
536/13.9

Sisomicin or derivative

59
536/14

Streptomycin or derivative

22
536/16

Addition compounds

7
536/15

Dihydrostreptomycin or derivative

6
536/2

Pectin or derivative

117
536/123

Plural diverse saccharides containing (e.g., hetero polysaccharides, etc.)

497
536/123.1

Polysaccharides

978
536/123.13

Disaccharides (e.g., maltose, sucrose, lactose, formaldehyde lactose, etc.)

319
536/123.12

Glucans (e.g., pullulan, etc.)

227
536/124

Processes

1592
536/125

Isomerization

74
536/126

Polymerization

138
536/127

Purification or recovery

572
536/128

From plant material

272
536/102

Starch or derivative

339
536/104

Aldehyde reaction product

45
536/106

Cross-linked

100
536/103

Dextrin or derivative

502
536/107

Esters

95
536/110

Carboxylic

89
536/108

Ether-esters or mixed esters

42
536/109

Phosphorus or sulfur containing

33
536/111

Ethers

131
536/105

Oxidized starch or derivative

92
536/122

Sulfur or halogen containing

321
 
 
  Recently Added Patents
Computer system and the computer control method
Plants and seeds of hybrid corn variety CH130744
3-arylphenyl sulfide derivative and insecticide and miticide
Semiconductor memory device
Structure of an electrode for use in an electrolytic cell
First output position calculation method, storage medium, positioning device, and electronic instrument
Method to produce a transponder
  Randomly Featured Patents
Circuit for stabilizing the black level in an output signal of a camera tube in a color television camera
Engraving and marking device particularly for machine tools and the like
Indicating device
Cosmetic film forming compositions
Process for the preparation of chloro-alkylbenzenes and novel cocatalysts therefor
Locally asynchronous, pipeline-able logic circuits for true-single-phase synchronous logic circuit
Flexible safety razors
Asset tracking using wireless LAN infrastructure
Stilbene compounds
Hydrofoil injection nozzle